Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'

por Ellsworth, Susannah, Grossman, Stuart A
Publicado 2015

CLRM-03 INCIDENCE OF INTRACRANIAL HEMORRHAGE IN GLIOMA PATIENTS WITH VENOUS THROMBOEMBOLISM CONVERTED FROM LMWH TO APIXABAN

por Aboud, Orwa, Ye, Xiaobu, Grossman, Stuart
Publicado 2022

THER-04. THE USE OF AN ADENOSINE A2 AGONIST TO IMPROVE THE PREVENTION AND TREATMENT OF BRAIN METASTASES

por Grossman, Stuart, Romo, Carlos, O’Connell, Kaelin
Publicado 2019

THER-08. BRAIN METASTASES AS A FIRST SITE OF RECURRENCE IN PATIENTS RECEIVING CHEMOTHERAPY WITH CONTROLLED SYSTEMIC CANCER: A CRITICAL BUT UNDER-RECOGNIZED CLINICAL SCENARIO

por O’Connell, Kaelin, Romo, Carlos, Grossman, Stuart
Publicado 2019

BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors

por Schreck, Karisa C., Grossman, Stuart A., Pratilas, Christine A.
Publicado 2019

Transient Opening of the Blood-Brain Barrier by Vasoactive Peptides to Increase CNS Drug Delivery: Reality Versus Wishful Thinking?

por Smith-Cohn, Matthew A., Burley, Nicholas B., Grossman, Stuart A.
Publicado 2022

Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors

por Diehl, Adam, Yarchoan, Mark, Hopkins, Alex, Jaffee, Elizabeth, Grossman, Stuart A.
Publicado 2017

Immune Control Despite Protracted Lymphopenia After Chemoradiation in an Elite Controller

por Reiss, Kim A., Jackson, Dvone C., Piotrowski, Anna, Grossman, Stuart, Blankson, Joel N.
Publicado 2016

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

por Ho, Won Jin, Yarchoan, Mark, Hopkins, Alex, Mehra, Ranee, Grossman, Stuart, Kang, Hyunseok
Publicado 2018

Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome

por Karmur, Brij S., Philteos, Justine, Abbasian, Aram, Zacharia, Brad E., Lipsman, Nir, Levin, Victor, Grossman, Stuart, Mansouri, Alireza
Publicado 2020

Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy

por Ellsworth, Susannah G., Yalamanchali, Anirudh, Lautenschlaeger, Tim, Grossman, Stuart A., Grassberger, Clemens, Lin, Steven H., Mohan, Radhe
Publicado 2022

In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders

por Kamson, David O., Chinnasamy, Viveka, Grossman, Stuart A., Bettegowda, Chetan, Barker, Peter B., Stacpoole, Peter W., Oeltzschner, Georg
Publicado 2023

Sustained CD4(+) T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide

por Ellsworth, Susannah, Balmanoukian, Ani, Kos, Ferdynand, Nirschl, Christopher J, Nirschl, Thomas R, Grossman, Stuart A, Luznik, Leo, Drake, Charles G
Publicado 2014

Adult precision medicine: learning from the past to enhance the future

por Ghiaseddin, Ashley, Hoang Minh, Lan B, Janiszewska, Michalina, Shin, David, Wick, Wolfgang, Mitchell, Duane A, Wen, Patrick Y, Grossman, Stuart A
Publicado 2020

2568 Pembrolizumab for patients with leptomeningeal disease from advanced solid tumors

por Naidoo, Jarushka, Hu, Chen, Schrek, Karisa, Connolly, Roisin, Santa-Maria, Cesar, Lipson, Evan, Mehra, Ranee, Bettegowda, Redmond, Kristin, Venkatesan, Arun, Grossman, Stuart
Publicado 2018

A Multi-Site Phase I Trial of Veliparib with Standard Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)

por Kleinberg, Lawrence, Ye, Xiaobu, Supko, Jeff, Stevens, Glenn H.J., Shu, Hui-Kuo, Mikkelsen, Tom, Lieberman, Frank, Lesser, Glenn, Lee, Emerson, Grossman, Stuart
Publicado 2023

Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal Malignancies

por Yalamanchali, Anirudh, Zhang, Hong, Huang, Ke Colin, Mohan, Radhe, Lin, Steven H., Zhu, Cong, Grossman, Stuart A., Jin, Jian-Yue, Ellsworth, Susannah G.
Publicado 2020

Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F...

por Swinnen, Lode J., O’Neill, Anne, Imus, Philip H., Gujar, Sachin, Schiff, David, Kleinberg, Lawrence R., Advani, Ranjana H., Dunbar, Erin M., Moore, Dennis, Grossman, Stuart A.
Publicado 2017

The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma

por Holdhoff, Matthias, Ye, Xiaobu, Piotrowski, Anna F., Strowd, Roy E., Seopaul, Shannon, Lu, Yao, Barker, Norman J., Sivakumar, Ananyaa, Rodriguez, Fausto J., Grossman, Stuart A., Burger, Peter C.
Publicado 2018

Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage

por Shen, Colette J., Kummerlowe, Megan N., Redmond, Kristin J., Martinez-Gutierrez, Juan Carlos, Usama, Syed Muhammad, Holdhoff, Matthias, Grossman, Stuart A., Laterra, John J., Strowd, Roy E., Kleinberg, Lawrence R.
Publicado 2018